313 related articles for article (PubMed ID: 36216484)
1. Renoprotective Effects of SGLT2 Inhibitors.
Vallon V
Heart Fail Clin; 2022 Oct; 18(4):539-549. PubMed ID: 36216484
[TBL] [Abstract][Full Text] [Related]
2. Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.
Vallon V; Verma S
Annu Rev Physiol; 2021 Feb; 83():503-528. PubMed ID: 33197224
[TBL] [Abstract][Full Text] [Related]
3. The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1.
Oe Y; Vallon V
Kidney Dial; 2022 Jun; 2(2):349-368. PubMed ID: 36380914
[TBL] [Abstract][Full Text] [Related]
4. Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System.
Poursharif S; Hamza S; Braam B
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232506
[TBL] [Abstract][Full Text] [Related]
5. The tubular hypothesis of nephron filtration and diabetic kidney disease.
Vallon V; Thomson SC
Nat Rev Nephrol; 2020 Jun; 16(6):317-336. PubMed ID: 32152499
[TBL] [Abstract][Full Text] [Related]
6. Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual framework.
Packer M
Diabetes Obes Metab; 2020 May; 22(5):734-742. PubMed ID: 31916329
[TBL] [Abstract][Full Text] [Related]
7. SGLT2 Inhibitors and the Diabetic Kidney.
Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
[TBL] [Abstract][Full Text] [Related]
8. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Packer M
Am J Kidney Dis; 2021 Feb; 77(2):280-286. PubMed ID: 32711072
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of SGLT2 inhibitors: an update.
Nespoux J; Vallon V
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):190-198. PubMed ID: 31815757
[TBL] [Abstract][Full Text] [Related]
11. Renal Effects of Sodium-Glucose Co-Transporter Inhibitors.
Thomson SC; Vallon V
Am J Cardiol; 2019 Dec; 124 Suppl 1(Suppl 1):S28-S35. PubMed ID: 31741437
[TBL] [Abstract][Full Text] [Related]
12. Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats.
Thomson SC; Vallon V
Am J Physiol Renal Physiol; 2021 May; 320(5):F761-F771. PubMed ID: 33645318
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease.
Ravindran S; Munusamy S
J Cell Physiol; 2022 Feb; 237(2):1182-1205. PubMed ID: 34713897
[TBL] [Abstract][Full Text] [Related]
14. SGLT2 inhibition and kidney protection.
Nespoux J; Vallon V
Clin Sci (Lond); 2018 Jun; 132(12):1329-1339. PubMed ID: 29954951
[TBL] [Abstract][Full Text] [Related]
15. Mitigation of the Adverse Consequences of Nutrient Excess on the Kidney: A Unified Hypothesis to Explain the Renoprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors.
Packer M
Am J Nephrol; 2020; 51(4):289-293. PubMed ID: 32126558
[TBL] [Abstract][Full Text] [Related]
16. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
[TBL] [Abstract][Full Text] [Related]
17. Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease.
Bailey CJ; Day C; Bellary S
Curr Diab Rep; 2022 Jan; 22(1):39-52. PubMed ID: 35113333
[TBL] [Abstract][Full Text] [Related]
18. Acute and Direct Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glomerular Filtration Rate in Spontaneously Diabetic Torii Fatty Rats.
Takakura S; Takasu T
Biol Pharm Bull; 2019; 42(10):1707-1712. PubMed ID: 31582658
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition.
Tsimihodimos V; Filippatos TD; Filippas-Ntekouan S; Elisaf M
Curr Vasc Pharmacol; 2017; 15(2):96-102. PubMed ID: 27748201
[TBL] [Abstract][Full Text] [Related]
20. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.
Vallon V; Thomson SC
Diabetologia; 2017 Feb; 60(2):215-225. PubMed ID: 27878313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
